Spectral Medical Announces Exercise of Warrants for Gross Proceeds of Approximately $3.0 Million
April 15, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, April 15, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical’s Dialco Medical Announces 20 Year Exclusive License Agreement for DIMI Hemodialysis System in the United States and Canada
April 08, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (“Dialco”) has...
Spectral Medical’s Wholly-Owned Subsidiary Dialco Medical Announces Receipt of Health Canada License for DIMI
March 31, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, March 31, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (“Dialco”) has...
Spectral Announces Fourth Quarter and Fiscal 2020 Results and Corporate Update
March 26, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, March 26, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Announces the Appointment of Chris Seto to CEO
March 08, 2021 08:00 ET
|
Spectral Medical Inc.
Dr. Paul Walker will remain on the Board of Directors focusing on the seamless transition of management and on ensuring continuity of the Tigris Trial TORONTO, March 08, 2021 (GLOBE NEWSWIRE) --...
Spectral Medical Engages Crescendo Communications to Provide Investor Relations Services in the United States
March 04, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical to participate at the upcoming H.C. Wainwright Global Life Sciences Conference
March 02, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic...
Spectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical has been Granted FDA IDE Authorization to Conduct a Trial of DIMI for Home Hemodialysis Use
February 23, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), today announced that its wholly-owned subsidiary, Dialco Medical Inc. (“Dialco”), has been...
Spectral Medical Appoints Dr. John Kellum as Chief Medical Officer
February 01, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical to Present at the H.C. Wainwright Virtual BioConnect Conference
January 11, 2021 08:00 ET
|
Spectral Medical Inc.
TORONTO, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...